Merawi Aragaw
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Merawi Aragaw has a total of 196 co-authors. Here are the top co-authors by number of shared publications:
Jean Kaseya
Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia
4 shared publications- Nebiyu Dereje
Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia
3 shared publications - Neema Kamara
Africa Centres for Disease Control and Prevention
3 shared publications Ngashi Ngongo
Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia
3 shared publications- Jean Kaseya
Africa Centres for Disease Control and Prevention
2 shared publications - Kyeng Mercy
Africa Centres for Disease Control and Prevention
2 shared publications
Latest Publications
- Open Access
- 15 September 2026
- Published by BMJ in BMJ Global Health
- Vol. 11 (9) , e023050
Mpox in Africa: one year continental response outcomes and way forward
Background: Following the declaration of mpox as both a global and continental public health emergency in August 2024, the Joint Incident Management Support Team (IMST), co-led by the Africa Centres for Disease Control and Prevention (Africa CDC) and the WHO, was activated in Kinshasa, DRC to coordinate the continental mpox response. This article highlights the first year’s epidemiological and operational findings. Methods: Key performance indicators across eight IMST pillars (coordination, surveillance, laboratory, case management, infection prevention and control, risk communication and community engagement (RCCE), vaccination and research) were descriptively analysed using data from 28 African Union Member States from January 2024 to August 2025. Results: A total of 49 803 confirmed cases and 240 deaths (CFR 0.5%) were recorded across 28 countries. The response was supported with US$977 million as tracked by the IMST. Operational achievements included 87% surveillance completeness, 72% contact tracing completeness and improved average laboratory turnaround time from >5 days to 2 days. Laboratory testing capacity expanded from 2 to 27 sites in the DRC and from 1 to 56 decentralised sites in Burundi. RCCE activities reached 50 million people in 21 countries, with vaccine acceptance among high-risk groups rising from 44% to 87%. Operational research achievements included a responsive and functional research coordination mechanism, 24 (92%, 24/26) multi-country clinical and operational research studies implemented and 60% completion rate of the research data and material sharing framework for Africa. Only 938 000 doses (32%) of the 3.1 million vaccine doses delivered were administered. Conclusion: The joint continental IMST is a new benchmark for response governance, successfully mobilising resources and scaling up diagnostics under unified co-leadership. On the other hand, the evaluation revealed persistent structural challenges in last-mile vaccine delivery, contact tracing (due to stigma/funding) and weak regional collaborative research including fragmented regional research priorities. Future focus must shift from emergency action to durable, sustained investment in national and sub-national health security architecture using a multisectoral whole of government approach.
- 15 September 2026
- Published by BMJ in BMJ Global Health
- Vol. 11 (9) , e023050
Open AccessMpox in Africa: one year continental response outcomes and way forward
Background: Following the declaration of mpox as both a global and continental public health emergency in August 2024, the Joint Incident Management Support Team (IMST), co-led by the Africa Centres for Disease Control and Prevention (Africa CDC) and the WHO, was activated in Kinshasa, DRC to coordinate the continental mpox response. This article highlights the first year’s epidemiological and operational findings. Methods: Key performance indicators across eight IMST pillars (coordination, surveillance, laboratory, case management, infection prevention and control, risk communication and community engagement (RCCE), vaccination and research) were descriptively analysed using data from 28 African Union Member States from January 2024 to August 2025. Results: A total of 49 803 confirmed cases and 240 deaths (CFR 0.5%) were recorded across 28 countries. The response was supported with US$977 million as tracked by the IMST. Operational achievements included 87% surveillance completeness, 72% contact tracing completeness and improved average laboratory turnaround time from >5 days to 2 days. Laboratory testing capacity expanded from 2 to 27 sites in the DRC and from 1 to 56 decentralised sites in Burundi. RCCE activities reached 50 million people in 21 countries, with vaccine acceptance among high-risk groups rising from 44% to 87%. Operational research achievements included a responsive and functional research coordination mechanism, 24 (92%, 24/26) multi-country clinical and operational research studies implemented and 60% completion rate of the research data and material sharing framework for Africa. Only 938 000 doses (32%) of the 3.1 million vaccine doses delivered were administered. Conclusion: The joint continental IMST is a new benchmark for response governance, successfully mobilising resources and scaling up diagnostics under unified co-leadership. On the other hand, the evaluation revealed persistent structural challenges in last-mile vaccine delivery, contact tracing (due to stigma/funding) and weak regional collaborative research including fragmented regional research priorities. Future focus must shift from emergency action to durable, sustained investment in national and sub-national health security architecture using a multisectoral whole of government approach.
- Open Access
- 27 January 2026
- Published by BMJ in BMJ Global Health
- Vol. 11 (1) , e022221
How effective are international deployments in strengthening low- and middle-income countries (LMICs) to respond to outbreaks in the long term?
Introduction : International public health deployments are frequently used to support outbreak response, but there is limited evidence of their long-term impact on national response systems. This study assessed the extent to which deployments contribute to long-term, sustained impacts on the national outbreak response capacities of African Union Member States. Methods : We used an exploratory sequential mixed-methods design for this study. We conducted 83 key informant interviews across ten countries, carried out two in-depth country case studies and administered an online survey among 304 stakeholders involved in international deployments from 28 African Union Member States. Qualitative data were analysed thematically. Adjusted ORs (aORs) and 95% CIs identified factors associated with perceived long-term, sustained impact of deployments using multivariable logistic regression. Results: International deployments contributed to long-term impacts in national outbreak response across three domains: (1) strengthened systems and protocols; (2) continued use of infrastructure and equipment introduced during deployments and (3) enhanced confidence, knowledge and leadership among national stakeholders. Case studies further illustrated how adaptive, context-aware, collaborative deployments fostered national ownership and institutional memory. Deployments that were timely (aOR 4.4, CI 1.3 to 15.2), supported by deploying agencies (aOR 9.1, CI 2.1 to 39.9) and involved flexible and adaptive deployees (aOR 12.1, CI 1.9 to 77.1) were more likely to make substantial impact on national outbreak response. Conclusion : International deployments contribute to the sustained impact of outbreak response, particularly when they are country-led and align with local priorities. The findings suggest that international deployments should be viewed not only as emergency surge mechanisms, but also as strategic opportunities for contributing to longer-term impacts on national systems. Future deployment models should prioritise developing soft skills of deployees, ensure deployments are timely, context-appropriate and supported with additional resources to maximise their enduring value.
- 27 January 2026
- Published by BMJ in BMJ Global Health
- Vol. 11 (1) , e022221
Open AccessHow effective are international deployments in strengthening low- and middle-income countries (LMICs) to respond to outbreaks in the long term?
Introduction : International public health deployments are frequently used to support outbreak response, but there is limited evidence of their long-term impact on national response systems. This study assessed the extent to which deployments contribute to long-term, sustained impacts on the national outbreak response capacities of African Union Member States. Methods : We used an exploratory sequential mixed-methods design for this study. We conducted 83 key informant interviews across ten countries, carried out two in-depth country case studies and administered an online survey among 304 stakeholders involved in international deployments from 28 African Union Member States. Qualitative data were analysed thematically. Adjusted ORs (aORs) and 95% CIs identified factors associated with perceived long-term, sustained impact of deployments using multivariable logistic regression. Results: International deployments contributed to long-term impacts in national outbreak response across three domains: (1) strengthened systems and protocols; (2) continued use of infrastructure and equipment introduced during deployments and (3) enhanced confidence, knowledge and leadership among national stakeholders. Case studies further illustrated how adaptive, context-aware, collaborative deployments fostered national ownership and institutional memory. Deployments that were timely (aOR 4.4, CI 1.3 to 15.2), supported by deploying agencies (aOR 9.1, CI 2.1 to 39.9) and involved flexible and adaptive deployees (aOR 12.1, CI 1.9 to 77.1) were more likely to make substantial impact on national outbreak response. Conclusion : International deployments contribute to the sustained impact of outbreak response, particularly when they are country-led and align with local priorities. The findings suggest that international deployments should be viewed not only as emergency surge mechanisms, but also as strategic opportunities for contributing to longer-term impacts on national systems. Future deployment models should prioritise developing soft skills of deployees, ensure deployments are timely, context-appropriate and supported with additional resources to maximise their enduring value.
- Open Access
- 1 January 2026
- Published by AOSIS in Journal of Public Health in Africa
- Vol. 17 (1)
Ebola disease outbreak caused by Bundibugyo virus in Africa: A defining moment for Africa’s health security and sovereignty
- 1 January 2026
- Published by AOSIS in Journal of Public Health in Africa
- Vol. 17 (1)
Open AccessEbola disease outbreak caused by Bundibugyo virus in Africa: A defining moment for Africa’s health security and sovereignty
- Open Access
- 1 January 2026
- Published by AOSIS in Journal of Public Health in Africa
- Vol. 17 (1) , 9
Prioritisation and risk ranking of epidemic-prone diseases for emergency preparedness and response in Eastern Africa using a multi-criteria decision analysis framework, 2023
Background: Resources to respond to emerging and re-emerging infectious disease emergencies are limited. Aim: To support preparedness planning and resource allocation, a prioritisation methodology was applied to rank epidemic-prone diseases in Eastern Africa. Setting: The study took place in the eastern region of Africa representing 14 member states. Methods: A multi-criteria decision analysis (MCDA) combined with a modified Delphi approach, adapted from the Africa Centres for Disease Control and Prevention (CDC’s) continental prioritisation framework was employed. A planning team of epidemiologists and infectious disease experts designed the exercise, implemented through a three-day workshop in Comoros from 9 May 2023 to 11 May 2023. The workshop convened 43 experts from Eastern Africa member states and partner organisations to rank diseases. Participants assessed each disease against 19 predefined criteria, grouped into four overarching domains: risk trajectory, epidemic potential, disease severity, and preparedness and medical countermeasures. Overall risk was calculated as the product of risk trajectory, epidemic potential, and disease severity. Results: Twenty-eight experts (88%, 28 of the eligible participants, n = 32) prioritised 22 potential epidemic-prone diseases. The top 10 were Ebola virus disease (risk = 12.7), Marburg virus disease (11.8), cholera (11.1), coronavirus disease 2019 (COVID-19) (9.9), influenza (8.9), measles (8.6), yellow fever (8.5), Crimean-Congo haemorrhagic fever (8.2), malaria (8.0) and Rift Valley fever (7.9). The unknown disease, defined as one caused by a hypothetical novel pathogen (often referred to as ‘Disease X’), Crimean-Congo haemorrhagic fever, Rift Valley fever and mpox received the lowest preparedness rating. Conclusion: Ebola virus disease (EVD), Marburg virus disease (MVD) and cholera ranked highest in risk, while unknown disease and zoonoses showed the lowest preparedness. Contribution: Amid current funding constraints, these findings provide evidence to guide Africa CDC and partners in strengthening emergency preparedness and response in Eastern Africa, highlighting priority diseases while underscoring the need for further analysis of capacity gaps.
- 1 January 2026
- Published by AOSIS in Journal of Public Health in Africa
- Vol. 17 (1) , 9
Open AccessPrioritisation and risk ranking of epidemic-prone diseases for emergency preparedness and response in Eastern Africa using a multi-criteria decision analysis framework, 2023
Background: Resources to respond to emerging and re-emerging infectious disease emergencies are limited. Aim: To support preparedness planning and resource allocation, a prioritisation methodology was applied to rank epidemic-prone diseases in Eastern Africa. Setting: The study took place in the eastern region of Africa representing 14 member states. Methods: A multi-criteria decision analysis (MCDA) combined with a modified Delphi approach, adapted from the Africa Centres for Disease Control and Prevention (CDC’s) continental prioritisation framework was employed. A planning team of epidemiologists and infectious disease experts designed the exercise, implemented through a three-day workshop in Comoros from 9 May 2023 to 11 May 2023. The workshop convened 43 experts from Eastern Africa member states and partner organisations to rank diseases. Participants assessed each disease against 19 predefined criteria, grouped into four overarching domains: risk trajectory, epidemic potential, disease severity, and preparedness and medical countermeasures. Overall risk was calculated as the product of risk trajectory, epidemic potential, and disease severity. Results: Twenty-eight experts (88%, 28 of the eligible participants, n = 32) prioritised 22 potential epidemic-prone diseases. The top 10 were Ebola virus disease (risk = 12.7), Marburg virus disease (11.8), cholera (11.1), coronavirus disease 2019 (COVID-19) (9.9), influenza (8.9), measles (8.6), yellow fever (8.5), Crimean-Congo haemorrhagic fever (8.2), malaria (8.0) and Rift Valley fever (7.9). The unknown disease, defined as one caused by a hypothetical novel pathogen (often referred to as ‘Disease X’), Crimean-Congo haemorrhagic fever, Rift Valley fever and mpox received the lowest preparedness rating. Conclusion: Ebola virus disease (EVD), Marburg virus disease (MVD) and cholera ranked highest in risk, while unknown disease and zoonoses showed the lowest preparedness. Contribution: Amid current funding constraints, these findings provide evidence to guide Africa CDC and partners in strengthening emergency preparedness and response in Eastern Africa, highlighting priority diseases while underscoring the need for further analysis of capacity gaps.
- Open Access
- 1 January 2026
- Published by AOSIS in Journal of Public Health in Africa
- Vol. 17 (1)
Addressing the need for an operational research framework for Africa
Africa Centres for Disease Control and Prevention (CDC), which supports all 55 member states (MS) in Africa, was established to strengthen the capacity and capability of Africa’s public health institutions to detect and respond quickly and effectively to disease threats and outbreaks based on science, policy, and data-driven interventions and programmes. This function is drawn from the African Union (AU) Assembly of Heads of State and Government, which adopted the statute of the Africa CDC in January 2016 and implemented it in mid-2017. Africa desperately needs an operational research (OR) framework for all 55 MS. The OR framework’s strategic aim is to strengthen the capacity to initiate, design and implement OR during disease outbreaks and emergencies. The framework, with support from the Africa CDC, will therefore provide a concise guide to institutional structures, procedures and standards, as well as an outline of methodologies and tools for conducting OR that is context-specific, while promoting the use of generated evidence for policy and decision makers. Drawing on expert reviews, we present here the need for the OR framework and the process of its development for research during public health emergencies in Africa.
- 1 January 2026
- Published by AOSIS in Journal of Public Health in Africa
- Vol. 17 (1)
Open AccessAddressing the need for an operational research framework for Africa
Africa Centres for Disease Control and Prevention (CDC), which supports all 55 member states (MS) in Africa, was established to strengthen the capacity and capability of Africa’s public health institutions to detect and respond quickly and effectively to disease threats and outbreaks based on science, policy, and data-driven interventions and programmes. This function is drawn from the African Union (AU) Assembly of Heads of State and Government, which adopted the statute of the Africa CDC in January 2016 and implemented it in mid-2017. Africa desperately needs an operational research (OR) framework for all 55 MS. The OR framework’s strategic aim is to strengthen the capacity to initiate, design and implement OR during disease outbreaks and emergencies. The framework, with support from the Africa CDC, will therefore provide a concise guide to institutional structures, procedures and standards, as well as an outline of methodologies and tools for conducting OR that is context-specific, while promoting the use of generated evidence for policy and decision makers. Drawing on expert reviews, we present here the need for the OR framework and the process of its development for research during public health emergencies in Africa.
- 30 July 2025
- Published by Springer Nature in Nature Medicine
- Vol. 31 (11) , 3588-3589
Key drivers for mpox control at its source to reduce costs amid aid cuts to Africa
- 30 July 2025
- Published by Springer Nature in Nature Medicine
- Vol. 31 (11) , 3588-3589
Key drivers for mpox control at its source to reduce costs amid aid cuts to Africa
- Open Access
- 1 January 2025
- Published by AOSIS in Journal of Public Health in Africa
- Vol. 16 (1) , 3
The Unified Continental Approach to the Mpox Outbreak Preparedness and Response: A Model for Future Outbreaks in Africa
The Journal of Public Health in Africa (JPHiA) is a peer-reviewed, academic journal that focuses on health issues in the African continent. The journal editors seek high quality original articles on public health related issues, reviews, comments and more. The aim of the journal is to move public health discourse from the background to the forefront. The success of Africa’s struggle against disease depends on public health approaches.
- 1 January 2025
- Published by AOSIS in Journal of Public Health in Africa
- Vol. 16 (1) , 3
Open AccessThe Unified Continental Approach to the Mpox Outbreak Preparedness and Response: A Model for Future Outbreaks in Africa
The Journal of Public Health in Africa (JPHiA) is a peer-reviewed, academic journal that focuses on health issues in the African continent. The journal editors seek high quality original articles on public health related issues, reviews, comments and more. The aim of the journal is to move public health discourse from the background to the forefront. The success of Africa’s struggle against disease depends on public health approaches.
- Open Access
- 16 December 2024
- Published by Springer Nature in Nature Medicine
- Vol. 31 (2) , 422-426
Genomic and transmission dynamics of the 2024 Marburg virus outbreak in Rwanda
The ongoing outbreak of Marburg virus disease in Rwanda marks the third largest historically, although it has shown the lowest fatality rate. Genomic analysis of samples from 18 cases identified a lineage with limited internal diversity, closely related to a 2014 Ugandan case. Our findings suggest that the Rwandan lineage diverged decades ago from a common ancestor shared with diversity sampled from bats in Uganda. Our genomic data reveal limited genetic variation, consistent with a single zoonotic transmission event and limited human-to-human transmission. Investigations including contact tracing, clinical assessments, sequencing and serology, linked the index case to a mining cave inhabited by Rousettus aegyptiacus. Serology tests identified three individuals seropositive for immunoglobulin G and immunoglobulin M, further supporting the zoonotic origin of the outbreak through human–animal interactions.
- 16 December 2024
- Published by Springer Nature in Nature Medicine
- Vol. 31 (2) , 422-426
Open AccessGenomic and transmission dynamics of the 2024 Marburg virus outbreak in Rwanda
The ongoing outbreak of Marburg virus disease in Rwanda marks the third largest historically, although it has shown the lowest fatality rate. Genomic analysis of samples from 18 cases identified a lineage with limited internal diversity, closely related to a 2014 Ugandan case. Our findings suggest that the Rwandan lineage diverged decades ago from a common ancestor shared with diversity sampled from bats in Uganda. Our genomic data reveal limited genetic variation, consistent with a single zoonotic transmission event and limited human-to-human transmission. Investigations including contact tracing, clinical assessments, sequencing and serology, linked the index case to a mining cave inhabited by Rousettus aegyptiacus. Serology tests identified three individuals seropositive for immunoglobulin G and immunoglobulin M, further supporting the zoonotic origin of the outbreak through human–animal interactions.
- 17 October 2024
- Published by Springer Nature in Nature Medicine
- Vol. 30 (12) , 3413-3416
How to prepare for the next inevitable Ebola outbreak: lessons from West Africa
- 17 October 2024
- Published by Springer Nature in Nature Medicine
- Vol. 30 (12) , 3413-3416
How to prepare for the next inevitable Ebola outbreak: lessons from West Africa
- 22 August 2024
- Published by Springer Nature in Nature Medicine
- Vol. 30 (10) , 2706-2707
A community engagement framework to accelerate the uptake of malaria vaccines in Africa
- 22 August 2024
- Published by Springer Nature in Nature Medicine
- Vol. 30 (10) , 2706-2707
A community engagement framework to accelerate the uptake of malaria vaccines in Africa